
GenScript Life Science Group is a part of GenScript Biotech Corporation. Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners—from academic institutions to industry leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has become a trusted global partner with a team of approximately 6,165 employees, supporting over 200,000 customers across 100+ countries and regions, including the world’s Top 20 pharma companies.
Unlock the market timeline & signal feed
New Partnerships activity — 1 fresh signal just appeared.
The order this company entered each market — oldest to newest
21 active postings
Intern - Biotechnologist (Protein)
Sign up to see the full signal feed
How GenScript's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
GenScriptYou | 8 | 1 | +28% | 91 | 36 |
Sales Account Manager
View postingSingapore, Singapore · 4d ago
Production Lead- LNP
View postingRedmond, WA · 4d ago
Technical Account Manager (Taiwan)
View postingTaiwangou, Taiwan, Taiwan · 4d ago
For Academic Researchers: Take Your Research Further
EndedExplore More About TurboCHO™ Kit
EndedEvaluar mi proyecto piloto de expresión de proteínas.
EndedGenScript opens mRNA facility in Delft, Netherlands, expanding global R&D network and strengthening European biotech infrastructure.
GenScript offers high-efficiency nucleic acid synthesis equipment with 99.5%+ coupling efficiency, covering micro to industrial-scale production for life sciences and biopharmaceutical research.
GenScript Biotech reports 81.9% revenue growth to $518.8M in H1 2025, with 509.6% increase in adjusted net profit to $178M, driven by global expansion and innovation across all business segments.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about GenScript's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.